<sup>177</sup>Lu-Dotatate administration using an infusion pump or a peristaltic pump: comparison of two methods.

Donzé, Charlotte; Rubira, Léa; Santoro, Lore; Viarasakd, Malissone; Kotzki, Pierre Olivier; Deshayes, Emmanuel; Fersing, Cyril

¹⁷⁷Lu-Dotatate administration using an infusion pump or a peristaltic pump: comparison of two methods.

Donzé, Charlotte; Rubira, Léa; Santoro, Lore; Viarasakd, Malissone; Kotzki, Pierre Olivier; Deshayes, Emmanuel; Fersing, Cyril.

Afiliação

Donzé C; Nuclear medicine department, Institut régional du Cancer de Montpellier (ICM), Univ. Montpellier, Montpellier, France.
Rubira L; Nuclear medicine department, Institut régional du Cancer de Montpellier (ICM), Univ. Montpellier, Montpellier, France.
Santoro L; Nuclear medicine department, Institut régional du Cancer de Montpellier (ICM), Univ. Montpellier, Montpellier, France.
Viarasakd M; Nuclear medicine department, Institut régional du Cancer de Montpellier (ICM), Univ. Montpellier, Montpellier, France.
Kotzki PO; Nuclear medicine department, Institut régional du Cancer de Montpellier (ICM), Univ. Montpellier, Montpellier, France.
Deshayes E; Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Univ. Montpellier, Institut régional du Cancer de Montpellier (ICM), Montpellier, France.
Fersing C; Nuclear medicine department, Institut régional du Cancer de Montpellier (ICM), Univ. Montpellier, Montpellier, France.

Eur J Hosp Pharm ; 2022 Sep 13.

Article em En | MEDLINE | ID: mdl-36100369

Palavras-chave

antineoplastic agents; drug administration routes; nuclear medicine; quality of health care; safety

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Eur J Hosp Pharm Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França